Cited by 392PI3K/AKT/mTOR signaling in cancerMuscle Physiology and DisordersMuscle metabolism and nutrition

Atrophy of S6K1(−/−) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control

Open access
Ohanna, Mickaël, Sobering, Andrew K., Lapointe, Thomas, Lorenzo, Lazaro, Praud, Christophe, Petroulakis, Emmanuel, Sonenberg, Nahum, Kelly, Paul A. +2 more·2005·Nature Cell Biology

Abstract

The mammalian target of rapamycin (mTOR) and Akt proteins regulate various steps of muscle development and growth, but the physiological relevance and the downstream effectors are under investigation. Here we show that S6 kinase 1 (S6K1), a protein kinase activated by nutrients and insulin-like growth factors (IGFs), is essential for the control of muscle cytoplasmic volume by Akt and mTOR. Deletion of S6K1 does not affect myoblast cell proliferation but reduces myoblast size to the same extent as that observed with mTOR inhibition by rapamycin. In the differentiated state, S6K1(-/-) myotubes have a normal number of nuclei but are smaller, and their hypertrophic response to IGF1, nutrients and membrane-targeted Akt is blunted. These growth defects reveal that mTOR requires distinct effectors for the control of muscle cell cycle and size, potentially opening new avenues of therapeutic intervention against neoplasia or muscle atrophy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncb1231

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Impairment of mTORC1 activity or its downstream target p70S6K1 impinges muscle mass.

    “When mTORC1 activity [89] or the activity of its down stream target p70S6K1 [92,93] are impaired then muscle mass is impinged.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ohanna, M., Sobering, A. K., Lapointe, T., Lorenzo, L., Praud, C., Petroulakis, E., Sonenberg, N., Kelly, P. A., Sotiropoulos, A., & Pende, M.
Affiliations
  • Hôpital Necker-Enfants Malades (FR)
  • McGill University (CA)
Corresponding author
  • Sotiropoulos, Athanassia
  • Pende, Mario
Venue
Nature Cell Biology
Published
2005-02-20
Volume
7
Issue
3
Pages
286-294
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W1998763810
Cited by
392
References
27
Citations by year
2026: 5 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 13 · 2020: 17 · 2019: 14 · 2018: 18 · 2017: 23 · 2016: 21 · 2015: 16 · 2014: 23 · 2013: 23 · 2012: 33
FWCI
9.95
Type
journal article
Language
en
Open access
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship@McGill (McGill) (submittedVersion)
  • HAL (submittedVersion)
Funders
  • Novartis Foundation
  • Institut National de la Santé et de la Recherche Médicale
  • Fondation pour la Recherche Médicale
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
Keywords
S6 kinase 1, mTOR, skeletal muscle atrophy, myoblast proliferation, cell cycle regulation, Akt signaling, insulin-like growth factor I, rapamycin, muscle hypertrophy
MeSH terms
Animals, Atrophy, Body Weight, Cell Differentiation, Cell Line, Cells, Cultured, Collagen, Drug Combinations, Genetic Vectors, Genotype, Homozygote, Humans, Laminin, Mice, Inbred C57BL, Models, Biological, Muscles, Plasmids, Protein Binding, Protein Kinases, Proteoglycans, Retroviridae, Somatomedins, Time Factors, Transfection, Immunoblotting, Signal Transduction, Gene Deletion, Muscle, Skeletal, Ribosomal Protein S6 Kinases, 70-kDa, Green Fluorescent Proteins, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review